Report by the Managing Board
Managing Board reportDSM performed well in 2007 with good sales growth and strong results in light of the challenges faced by the company during the year.
Net sales and supplies
|
x € million
|
Net sales
|
Supplies
|
||
|
|
2007
|
2006
|
2007
|
2006
|
|
|
|
|
|
|
|
Nutrition
|
2,543
|
2,407
|
2,590
|
2,463
|
|
Pharma
|
981
|
916
|
1,031
|
967
|
|
Performance Materials
|
2,895
|
2,753
|
2,901
|
2,759
|
|
Industrial Chemicals
|
1,937
|
1,872
|
2,205
|
2,135
|
|
Other activities
|
401
|
404
|
455
|
422
|
|
Intra-group supplies
|
-
|
-
|
(425)
|
(394)
|
|
|
|
|
|
|
|
Total, continuing operations
|
8,757
|
8,352
|
8,757
|
8,352
|
|
Discontinued operations
|
-
|
28
|
-
|
28
|
|
|
|
|
|
|
|
Total DSM
|
8,757
|
8,380
|
8,757
|
8,380
|
Operating profit plus depreciation and amortization (EBITDA)
|
x € million
|
2007
|
2006
|
|
|
|
|
|
Nutrition
|
405
|
464
|
|
Pharma
|
174
|
146
|
|
Performance Materials
|
415
|
429
|
|
Industrial Chemicals
|
292
|
269
|
|
Other activities
|
(39)
|
(33)
|
|
|
|
|
|
Total, continuing operations
|
1,247
|
1,275
|
|
Discontinued operations
|
-
|
(1)
|
|
|
|
|
|
Total DSM
|
1,247
|
1,274
|
Operating profit (EBIT)
|
x € million
|
2007
|
2006
|
|
|
|
|
|
Nutrition
|
264
|
314
|
|
Pharma
|
93
|
65
|
|
Performance Materials
|
321
|
329
|
|
Industrial Chemicals
|
225
|
196
|
|
Other activities
|
(80)
|
(69)
|
|
|
|
|
|
Total, continuing operations
|
823
|
835
|
|
Discontinued operations
|
-
|
(1)
|
|
|
|
|
|
Total DSM
|
823
|
834
|
